Patients with both multiple myeloma and diabetes experienced reduced OS compared with those without diabetes, according to study results published in Blood Advances.
Of note, results of a subgroup analysis specifically showed worse OS among white patients with multiple myeloma and diabetes compared with Black study participants.
“We knew from prior studies that patients with multiple myeloma and diabetes have lower survival rates,” Urvi Shah, MD, a multiple myeloma specialist at Memorial Sloan Kettering Cancer Center, said in a press release. “But what we did not know is how
